Specifically, we examined the expression of Akt1m in primary cancers from BRCA1 conditional knockout mice (Brca1-/-), PtenG129E mutant females as well as transgenic mice that overexpress ERBB2 (MMTV-neu) and prolactin (NRL-PRL). This evidence concerns the gene PRL and cancer.